Pharmaceutical Testing and Analytical Services Market

Pharmaceutical Testing and Analytical Services Market (Service Type: Bioanalytical Testing, Method Development & Validation, Raw Material Testing, Stability Testing, Microbial Testing, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

Pharmaceutical Testing and Analytical Services Market Outlook 2034

  • The global industry was valued at US$ 8.3 Bn in 2023
  • It is expected to grow at a CAGR of 8.0% from 2024 to 2034 and reach US$ 19.7 Bn by the end of 2034

Analyst Viewpoint

Increase in demand for analytical services in pharmaceuticals is a prominent factor driving the global pharmaceutical testing and analytical services market growth. Bioanalytical testing helps check if a drug is in working condition or subject to any adverse effects.

It also helps ascertain whether or not the prescribed formulation should be continued. Speedy approval process of clinical trials and new drugs by regulatory bodies is also expediting the market for drug analysis services.

Companies operating in the global pharmaceutical testing and analytical services market are adopting the smart quality approach to integrate quality control in manufacture and development of pharmaceuticals.

Labs are likely to achieve productivity enhancement by 150% to 200% of their existing rates by adhering to smart quality control, as shorter testing time and improved agility are capable of reducing lead times by 60% to 70%.

Pharmaceutical Testing and Analytical Services Market Overview

Analytical services play a vital role with respect to safety, quality, and efficacy of pharmaceutical products throughout the development lifecycle, from early stages of development to manufacturing at the commercial scale.

Pharmacological testing refers to non-human tests in laboratories. The results are then shared with regulatory bodies such as the U.S. FDA to determine if the treatment is safe to be experimented with human volunteers.

Governments of several countries across the globe are taking initiatives to strengthen their analytical testing capabilities.

For instance, the Government of China recently issued notification regarding upgrade of the quality of generic drugs, elimination of the backlog of drug applications, improvement in quality of approval and review, and encouragement of extensive research to suffice the requirement of medicines at the global level.

However, drug testing specimens are likely to be tampered through adulteration or dilution. Furthermore, the process of sample collection can be time-consuming. These factors are projected to restrain the pharmaceutical testing and analytical services market dynamics and future analysis to a certain extent.

Attribute Detail
Market Drivers
  • Rise in Demand for Analytical Testing Services
  • Increase in Number of Approvals of Clinical Trials and Drugs

Growth in Demand for Analytical Testing Services Driving Pharmaceutical Testing and Analytical Services Market Size

Increase in the frequency of pharmaceutical testing methods, emphasis on core competencies of pharmaceuticals, and emergence of outsourcing of pharmaceuticals are driving the need for pharmaceutical analytical testing.

In July 2021, LGM Pharma announced that it had introduced analytics services offerings to provide analytical testing as well as stability services to the pharmaceutical sector.

Advanced pharmaceutical analytical testing solutions comprise real-time product quality control rendered by biopharmaceutical companies to differentiate between biosimilars and biologics.

Key participants use advanced equipment such as High-Resolution Accurate Mass Spectrometry (HRAM) instrument, fully validated laboratory information & management systems (LIMS), morphologically directed Raman spectroscopy (MDRS), and harmonized data acquisition applications software to provide efficient outsourcing services.

Pharmaceutical companies prefer outsourcing their analytical testing programs at an earlier stage of the product development lifecycle in order to concentrate on their core therapeutics strengths.

Thus, pharmaceutical quality control is the epicenter of the pharmaceutical testing and analytical services industry.

Increase in Number of Approvals of Clinical Trials and Drugs Boosting Pharmaceutical Testing and Analytical Services Market Demand and Business Opportunities

Speedy approval of drugs and clinical trials worldwide is driving the demand for advanced pharmaceutical analytical testing solutions. For instance, the U.S. FDA approved 50 new therapeutics in 2021, which gives the five-year average as 51 drugs per year.

In April 2022, the WHO confirmed that almost 349 vaccines were being developed. Eurofins Scientific extended support to the testing of Ad26.COV2.S. It was Johnson & Johnson’s investigational Covid-19 vaccine candidate.

Drugs that are forwarded to regulatory bodies are categorized as new molecular entities (NMEs) under New Drug Applications (NDAs) and novel therapeutic biologics under Biologics License Applications (BLA).

Clinical trials are also being registered at a faster pace. For instance, as per Clinicaltrial.gov 2022 update, 433,207 studies were registered in 2020; of these, 31% are registered in the U.S.

Thus, rise in number of approvals of drugs and clinical trials is augmenting the pharmaceutical testing and analytical services market.

Pharmaceutical Testing and Analytical Services Market Insights and Regional Analysis

Attribute Detail
Leading Region North America

North America accounted for the largest pharmaceutical testing and analytical services market share in 2022. The region is projected to maintain its dominant position during the forecast period.

According to the Center for Drug Evaluation and Research (CDER), 50 drugs were approved in the U.S. alone in 2021. High product approval in the U.S. is augmenting market progress in North America.

Establishment of several pharmaceutical and biopharmaceutical companies in Europe and Asia Pacific is bolstering the demand for pharmaceutical quality control analysis in these regions. WHO-cGMP compliance facilities are propagating pharma outsourcing trends.

Analysis of Key players in Pharmaceutical Testing and Analytical Services Market

Companies in pharmaceutical testing and analytical services industry are engaged in new product launches as well as indirect modes of expansion such as mergers & acquisitions to strengthen their market position.

In March 2022, Transgene presented a poster displaying a promising preliminary Phase I data regarding TG4050, its exclusive Neoantigen cancer vaccine, at the American Association for Cancer Research (AACR) annual meeting 2022

In November 2021, Eurofins announced that it had acquired Modern Testing Service with the objective of leading the testing, inspection, and certification (TIC) industry for consumer products.

The market report profiles leading players such as Eurofins Scientific, Laboratory Corporation of America Holdings, Charles river Laboratories International, Inc., SGS S.A., Intertek Group plc, RD laboratories, Inc., Wuxi AppTec Co., Ltd., DYNALABS LLC (Infinity Laboratories), and ARL Bio Pharma based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.

Key Developments

  • In March 2021, Teracero Pharma, along with nal von Minden GmbH, announced that the latter’s NADAL Covid-19 IgG/IgM test had received an authorization for commercialization and imports by Health Canada
  • In October 2021, Eurofins completed the acquisition of Biotech Laboratories from Sullivan & Nicolaides Pathology/Sonic Healthcare

Pharmaceutical Testing and Analytical Services Market Snapshot

Attribute Detail
Market Size in 2023 US$ 8.3 Bn
Market Forecast (Value) in 2034 US$ 19.7 Bn
Growth Rate (CAGR) 8.0%
Forecast Period 2024-2034
Historical Data Available for 2020-2022
Quantitative Units US$ Bn for Value
Market Analysis It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.
Competition Landscape
  • Market share analysis by company (2023)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format Electronic (PDF) + Excel
Market Segmentation
  • Service Type
    • Bioanalytical Testing (Cell-based Assays, Virology Testing, and Others)
    • Method Development & Validation (Extractables & Leachables Method Development and Validation, Stability-indicating Method Validation, Process Impurity Method Development & Validation, and Others)
    • Raw Material Testing (Heavy Metal Testing, Complete Compendial Testing, and Others)
    • Stability Testing (Drug Substance Stability Testing, Formulation Evaluation Stability Testing, and Others)
    • Microbial Testing (Microbial Limit Testing, Sterility Testing, Endotoxin Testing, and Others)
    • Others
  • End-user
    • Medical Device Companies
    • Pharmaceutical & Biopharmaceutical Companies
    • Others
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • South Africa
  • GCC
Companies Profiled
  • Eurofins Scientific
  • Laboratory Corporation of America Holdings
  • Charles River Laboratories International, Inc.
  • SGS S.A.
  • Intertek Group plc
  • RD laboratories, Inc.
  • Wuxi AppTec Co., Ltd.
  • DYNALABS LLC (Infinity Laboratories)
  • ARL Bio Pharma
Customization Scope Available Upon Request
Pricing Available Upon Request

Frequently Asked Questions

How big was the global pharmaceutical testing and analytical services market in 2023?

It was valued at US$ 8.3 Bn in 2023

How is the pharmaceutical testing and analytical services business expected to grow during the forecast period?

It is projected to grow at a CAGR of 8.0% from 2024 to 2034

What are the key factors driving the demand for pharmaceutical testing and analytical services?

Rise in demand for analytical testing services and increase in number of approvals of clinical trials and drugs

Which pharmaceutical testing and analytical services end-user segment held the largest share in 2023?

The medical device companies segment accounted for the largest share in 2022

Which region dominated the global pharmaceutical testing and analytical services landscape in 2023?

North America was the dominant region in 2023

Who are the key pharmaceutical testing and analytical service providers?

Eurofins Scientific, Laboratory Corporation of America Holdings, Charles River Laboratories International, Inc., SGS S.A., Intertek Group plc, RD laboratories, Inc., Wuxi AppTec Co., Ltd., DYNALABS LLC (Infinity Laboratories), and ARL Bio Pharma

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Pharmaceutical Testing and Analytical Services Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Product Definition

            4.1.2. Industry Evolution/Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Pharmaceutical Testing and Analytical Services Market Analysis and Forecast, 2020-2034

    5. Key Insights

        5.1. Pipeline Analysis

        5.2. Key Product/Brand Analysis

        5.3. Key Mergers & Acquisitions

        5.4. COVID-19 Pandemic Impact on Industry

    6. Global Pharmaceutical Testing and Analytical Services Market Analysis and Forecast, by Service Type

        6.1. Introduction & Definition

        6.2. Key Findings/Developments

        6.3. Market Value Forecast, by Service Type, 2020-2034

            6.3.1. Bioanalytical Testing

                6.3.1.1. Cell-based Assays

                6.3.1.2. Virology Testing

                6.3.1.3. Others

            6.3.2. Method Development & Validation

                6.3.2.1. Extractables & Leachables Method Development and Validation

                6.3.2.2. Stability-indicating Method Validation

                6.3.2.3. Process Impurity Method Development & Validation

                6.3.2.4. Others

            6.3.3. Raw Material Testing

                6.3.3.1. Heavy Metal Testing

                6.3.3.2. Complete Compendial Testing

                6.3.3.3. Others

            6.3.4. Stability Testing

                6.3.4.1. Drug Substance Stability Testing

                6.3.4.2. Formulation Evaluation Stability Testing

                6.3.4.3. Others

            6.3.5. Microbial Testing

                6.3.5.1. Microbial Limit Testing

                6.3.5.2. Sterility Testing

                6.3.5.3. Endotoxin Testing

                6.3.5.4. Others

            6.3.6. Others

        6.4. Market Attractiveness Analysis, by Service Type

    7. Global Pharmaceutical Testing and Analytical Services Market Analysis and Forecast, by End-user

        7.1. Introduction & Definition

        7.2. Key Findings/Developments

        7.3. Market Value Forecast, by End-user, 2020-2034

            7.3.1. Medical Device Companies

            7.3.2. Pharmaceutical & Biopharmaceutical Companies

            7.3.3. Others

        7.4. Market Attractiveness Analysis, by End-user

    8. Global Pharmaceutical Testing and Analytical Services Market Analysis and Forecast, by Region

        8.1. Key Findings

        8.2. Market Value Forecast, by Region, 2020-2034

            8.2.1. North America

            8.2.2. Europe

            8.2.3. Asia Pacific

            8.2.4. Latin America

            8.2.5. Middle East & Africa

        8.3. Market Attractiveness Analysis, by Region

    9. North America Pharmaceutical Testing and Analytical Services Market Analysis and Forecast

        9.1. Introduction

        9.2. Key Findings

        9.3. Market Value Forecast, by Service Type, 2020-2034

            9.3.1. Bioanalytical Testing

                9.3.1.1. Cell-based Assays

                9.3.1.2. Virology Testing

                9.3.1.3. Others

            9.3.2. Method Development & Validation

                9.3.2.1. Extractables & Leachables Method Development and Validation

                9.3.2.2. Stability-indicating Method Validation

                9.3.2.3. Process Impurity Method Development & Validation

                9.3.2.4. Others

            9.3.3. Raw Material Testing

                9.3.3.1. Heavy Metal Testing

                9.3.3.2. Complete Compendial Testing

                9.3.3.3. Others

            9.3.4. Stability Testing

                9.3.4.1. Drug Substance Stability Testing

                9.3.4.2. Formulation Evaluation Stability Testing

                9.3.4.3. Others

            9.3.5. Microbial Testing

                9.3.5.1. Microbial Limit Testing

                9.3.5.2. Sterility Testing

                9.3.5.3. Endotoxin Testing

                9.3.5.4. Others

            9.3.6. Others

        9.4. Market Value Forecast, by End-user, 2020-2034

            9.4.1. Medical Device Companies

            9.4.2. Pharmaceutical & Biopharmaceutical Companies

            9.4.3. Others

        9.5. Market Value Forecast, by Country, 2020-2034

            9.5.1. U.S.

            9.5.2. Canada

        9.6. Market Attractiveness Analysis

            9.6.1. By Service Type

            9.6.2. By End-user

            9.6.3. By Country

    10. Europe Pharmaceutical Testing and Analytical Services Market Analysis and Forecast

        10.1. Introduction

        10.2. Key Findings

        10.3. Market Value Forecast, by Service Type, 2020-2034

            10.3.1. Bioanalytical Testing

                10.3.1.1. Cell-based Assays

                10.3.1.2. Virology Testing

                10.3.1.3. Others

            10.3.2. Method Development & Validation

                10.3.2.1. Extractables & Leachables Method Development and Validation

                10.3.2.2. Stability-indicating Method Validation

                10.3.2.3. Process Impurity Method Development & Validation

                10.3.2.4. Others

            10.3.3. Raw Material Testing

                10.3.3.1. Heavy Metal Testing

                10.3.3.2. Complete Compendial Testing

                10.3.3.3. Others

            10.3.4. Stability Testing

                10.3.4.1. Drug Substance Stability Testing

                10.3.4.2. Formulation Evaluation Stability Testing

                10.3.4.3. Others

            10.3.5. Microbial Testing

                10.3.5.1. Microbial Limit Testing

                10.3.5.2. Sterility Testing

                10.3.5.3. Endotoxin Testing

                10.3.5.4. Others

            10.3.6. Others

        10.4. Market Value Forecast, by End-user, 2020-2034

            10.4.1. Medical Device Companies

            10.4.2. Pharmaceutical & Biopharmaceutical Companies

            10.4.3. Others

        10.5. Market Value Forecast, by Country/Sub-region, 2020-2034

            10.5.1. Germany

            10.5.2. U.K.

            10.5.3. France

            10.5.4. Italy

            10.5.5. Spain

            10.5.6. Rest of Europe

        10.6. Market Attractiveness Analysis

            10.6.1. By Service Type

            10.6.2. By End-user

            10.6.3. By Country/Sub-region

    11. Asia Pacific Pharmaceutical Testing and Analytical Services Market Analysis and Forecast

        11.1. Introduction

        11.2. Key Findings

        11.3. Market Value Forecast, by Service Type, 2020-2034

            11.3.1. Bioanalytical Testing

                11.3.1.1. Cell-based Assays

                11.3.1.2. Virology Testing

                11.3.1.3. Others

            11.3.2. Method Development & Validation

                11.3.2.1. Extractables & Leachables Method Development and Validation

                11.3.2.2. Stability-indicating Method Validation

                11.3.2.3. Process Impurity Method Development & Validation

                11.3.2.4. Others

            11.3.3. Raw Material Testing

                11.3.3.1. Heavy Metal Testing

                11.3.3.2. Complete Compendial Testing

                11.3.3.3. Others

            11.3.4. Stability Testing

                11.3.4.1. Drug Substance Stability Testing

                11.3.4.2. Formulation Evaluation Stability Testing

                11.3.4.3. Others

            11.3.5. Microbial Testing

                11.3.5.1. Microbial Limit Testing

                11.3.5.2. Sterility Testing

                11.3.5.3. Endotoxin Testing

                11.3.5.4. Others

            11.3.6. Others

        11.4. Market Value Forecast, by End-user, 2020-2034

            11.4.1. Medical Device Companies

            11.4.2. Pharmaceutical & Biopharmaceutical Companies

            11.4.3. Others

        11.5. Market Value Forecast, by Country/Sub-region, 2020-2034

            11.5.1. China

            11.5.2. Japan

            11.5.3. India

            11.5.4. Australia & New Zealand

            11.5.5. Rest of Asia Pacific

        11.6. Market Attractiveness Analysis

            11.6.1. By Service Type

            11.6.2. By End-user

            11.6.3. By Country/Sub-region

    12. Latin America Pharmaceutical Testing and Analytical Services Market Analysis and Forecast

        12.1. Introduction

        12.2. Key Findings

        12.3. Market Value Forecast, by Service Type, 2020-2034

            12.3.1. Bioanalytical Testing

                12.3.1.1. Cell-based Assays

                12.3.1.2. Virology Testing

                12.3.1.3. Others

            12.3.2. Method Development & Validation

                12.3.2.1. Extractables & Leachables Method Development and Validation

                12.3.2.2. Stability-indicating Method Validation

                12.3.2.3. Process Impurity Method Development & Validation

                12.3.2.4. Others

            12.3.3. Raw Material Testing

                12.3.3.1. Heavy Metal Testing

                12.3.3.2. Complete Compendial Testing

                12.3.3.3. Others

            12.3.4. Stability Testing

                12.3.4.1. Drug Substance Stability Testing

                12.3.4.2. Formulation Evaluation Stability Testing

                12.3.4.3. Others

            12.3.5. Microbial Testing

                12.3.5.1. Microbial Limit Testing

                12.3.5.2. Sterility Testing

                12.3.5.3. Endotoxin Testing

                12.3.5.4. Others

            12.3.6. Others

        12.4. Market Value Forecast, by End-user, 2020-2034

            12.4.1. Medical Device Companies

            12.4.2. Pharmaceutical & Biopharmaceutical Companies

            12.4.3. Others

        12.5. Market Value Forecast, by Country/Sub-region, 2020-2034

            12.5.1. Brazil

            12.5.2. Mexico

            12.5.3. Rest of Latin America

        12.6. Market Attractiveness Analysis

            12.6.1. By Service Type

            12.6.2. By End-user

            12.6.3. By Country/Sub-region

    13. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Analysis and Forecast

        13.1. Introduction

        13.2. Key Findings

        13.3. Market Value Forecast, by Service Type, 2020-2034

            13.3.1. Bioanalytical Testing

                13.3.1.1. Cell-based Assays

                13.3.1.2. Virology Testing

                13.3.1.3. Others

            13.3.2. Method Development & Validation

                13.3.2.1. Extractables & Leachables Method Development and Validation

                13.3.2.2. Stability-indicating Method Validation

                13.3.2.3. Process Impurity Method Development & Validation

                13.3.2.4. Others

            13.3.3. Raw Material Testing

                13.3.3.1. Heavy Metal Testing

                13.3.3.2. Complete Compendial Testing

                13.3.3.3. Others

            13.3.4. Stability Testing

                13.3.4.1. Drug Substance Stability Testing

                13.3.4.2. Formulation Evaluation Stability Testing

                13.3.4.3. Others

            13.3.5. Microbial Testing

                13.3.5.1. Microbial Limit Testing

                13.3.5.2. Sterility Testing

                13.3.5.3. Endotoxin Testing

                13.3.5.4. Others

            13.3.6. Others

        13.4. Market Value Forecast, by End-user, 2020-2034

            13.4.1. Medical Device Companies

            13.4.2. Pharmaceutical & Biopharmaceutical Companies

            13.4.3. Others

        13.5. Market Value Forecast, by Country/Sub-region, 2020-2034

            13.5.1. GCC Countries

            13.5.2. South Africa

            13.5.3. Rest of Middle East & Africa

        13.6. Market Attractiveness Analysis

            13.6.1. By Service Type

            13.6.2. By End-user

            13.6.3. By Country/Sub-region

    14. Competition Landscape

        14.1. Market Player - Competitive Matrix (by Tier and Size of Companies)

        14.2. Market Share Analysis, by Company (2023)

        14.3. Company Profiles

            14.3.1. Eurofins Scientific

                14.3.1.1. Company Overview

                14.3.1.2. Product Portfolio

                14.3.1.3. SWOT Analysis

                14.3.1.4. Financial Overview

                14.3.1.5. Strategic Overview

            14.3.2. Laboratory Corporation of America Holdings

                14.3.2.1. Company Overview

                14.3.2.2. Product Portfolio

                14.3.2.3. SWOT Analysis

                14.3.2.4. Financial Overview

                14.3.2.5. Strategic Overview

            14.3.3. Charles River Laboratories International, Inc.

                14.3.3.1. Company Overview

                14.3.3.2. Product Portfolio

                14.3.3.3. SWOT Analysis

                14.3.3.4. Financial Overview

                14.3.3.5. Strategic Overview

            14.3.4. SGS S.A.

                14.3.4.1. Company Overview

                14.3.4.2. Product Portfolio

                14.3.4.3. SWOT Analysis

                14.3.4.4. Financial Overview

                14.3.4.5. Strategic Overview

            14.3.5. Intertek Group plc

                14.3.5.1. Company Overview

                14.3.5.2. Product Portfolio

                14.3.5.3. SWOT Analysis

                14.3.5.4. Financial Overview

                14.3.5.5. Strategic Overview

            14.3.6. RD laboratories, Inc.

                14.3.6.1. Company Overview

                14.3.6.2. Product Portfolio

                14.3.6.3. SWOT Analysis

                14.3.6.4. Financial Overview

                14.3.6.5. Strategic Overview

            14.3.7. Wuxi AppTec Co., Ltd.

                14.3.7.1. Company Overview

                14.3.7.2. Product Portfolio

                14.3.7.3. SWOT Analysis

                14.3.7.4. Financial Overview

                14.3.7.5. Strategic Overview

            14.3.8. DYNALABS LLC (Infinity Laboratories)

                14.3.8.1. Company Overview

                14.3.8.2. Product Portfolio

                14.3.8.3. SWOT Analysis

                14.3.8.4. Financial Overview

                14.3.8.5. Strategic Overview

            14.3.9. ARL Bio Pharma

                14.3.9.1. Company Overview

                14.3.9.2. Product Portfolio

                14.3.9.3. SWOT Analysis

                14.3.9.4. Financial Overview

                14.3.9.5. Strategic Overview

    List of Tables

    Table 01: Global Pharmaceutical Testing and Analytical Services Market Size (US$ Mn) Forecast, by Service Type, 2020-2034

    Table 02: Global Pharmaceutical Testing and Analytical Services Market Size (US$ Mn) Forecast, by End-user, 2020-2034

    Table 03: Global Pharmaceutical Testing and Analytical Services Market Size (US$ Mn) Forecast, by Region, 2020-2034

    Table 04: North America Pharmaceutical Testing and Analytical Services Market Size (US$ Mn) Forecast, by Country, 2020-2034

    Table 05: North America Pharmaceutical Testing and Analytical Services Market Size (US$ Mn) Forecast, by Service Type, 2020-2034

    Table 06: North America Pharmaceutical Testing and Analytical Services Market Size (US$ Mn) Forecast, by End-user, 2020-2034

    Table 07: Europe Pharmaceutical Testing and Analytical Services Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

    Table 08: Europe Pharmaceutical Testing and Analytical Services Market Size (US$ Mn) Forecast, by Service Type, 2020-2034

    Table 09: Europe Pharmaceutical Testing and Analytical Services Market Size (US$ Mn) Forecast, by End-user, 2020-2034

    Table 10: Asia Pacific Pharmaceutical Testing and Analytical Services Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

    Table 11: Asia Pacific Pharmaceutical Testing and Analytical Services Market Size (US$ Mn) Forecast, by Service Type, 2020-2034

    Table 12: Asia Pacific Pharmaceutical Testing and Analytical Services Market Size (US$ Mn) Forecast, by End-user, 2020-2034

    Table 13: Latin America Pharmaceutical Testing and Analytical Services Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

    Table 14: Latin America Pharmaceutical Testing and Analytical Services Market Size (US$ Mn) Forecast, by Service Type, 2020-2034

    Table 15: Latin America Pharmaceutical Testing and Analytical Services Market Size (US$ Mn) Forecast, by End-user, 2020-2034

    Table 16: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

    Table 17: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Size (US$ Mn) Forecast, by Service Type, 2020-2034

    Table 18: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Size (US$ Mn) Forecast, by End-user, 2020-2034

    List of Figures

    Figure 01: Global Pharmaceutical Testing and Analytical Services Market Size (US$ Mn) and Distribution (%), by Region, 2023 and 2034

    Figure 02: Global Pharmaceutical Testing and Analytical Services Market Revenue (US$ Mn), by Service Type, 2023

    Figure 03: Global Pharmaceutical Testing and Analytical Services Market Value Share, by Service Type, 2023

    Figure 04: Global Pharmaceutical Testing and Analytical Services Market Revenue (US$ Mn), by End-user, 2023

    Figure 05: Global Pharmaceutical Testing and Analytical Services Market Value Share, by End-user, 2023

    Figure 06: Global Pharmaceutical Testing and Analytical Services Market Value Share, by Region, 2023

    Figure 07: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, 2020-2034

    Figure 08: Global Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by Service Type, 2023 and 2034

    Figure 09: Global Pharmaceutical Testing and Analytical Services Market Attractiveness Analysis, by Service Type, 2020-2034

    Figure 10: Global Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by End-user, 2023 and 2034

    Figure 11: Global Pharmaceutical Testing and Analytical Services Market Attractiveness Analysis, by End-user, 2020-2034

    Figure 12: Global Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by Region, 2023 and 2034

    Figure 13: Global Pharmaceutical Testing and Analytical Services Market Attractiveness Analysis, by Region, 2020-2034

    Figure 14: North America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

    Figure 15: North America Pharmaceutical Testing and Analytical Services Market Attractiveness Analysis, by Country, 2020-2034

    Figure 16: North America Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by Country, 2023 and 2034

    Figure 17: North America Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by Service Type, 2023 and 2034

    Figure 18: North America Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by End-user, 2023 and 2034

    Figure 19: North America Pharmaceutical Testing and Analytical Services Market Attractiveness Analysis, by Service Type, 2020-2034

    Figure 20: North America Pharmaceutical Testing and Analytical Services Market Attractiveness Analysis, by End-user, 2020-2034

    Figure 21: Europe Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

    Figure 22: Europe Pharmaceutical Testing and Analytical Services Market Attractiveness Analysis, by Country/Sub-region, 2020-2034

    Figure 23: Europe Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

    Figure 24: Europe Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by Service Type, 2023 and 2034

    Figure 25: Europe Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by End-user, 2023 and 2034

    Figure 26: Europe Pharmaceutical Testing and Analytical Services Market Attractiveness Analysis, by Service Type, 2020-2034

    Figure 27: Europe Pharmaceutical Testing and Analytical Services Market Attractiveness Analysis, by End-user, 2020-2034

    Figure 28: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

    Figure 29: Asia Pacific Pharmaceutical Testing and Analytical Services Market Attractiveness Analysis, by Country/Sub-region, 2020-2034

    Figure 30: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

    Figure 31: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by Service Type, 2023 and 2034

    Figure 32: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by End-user, 2023 and 2034

    Figure 33: Asia Pacific Pharmaceutical Testing and Analytical Services Market Attractiveness Analysis, by Service Type, 2020-2034

    Figure 34: Asia Pacific Pharmaceutical Testing and Analytical Services Market Attractiveness Analysis, by End-user, 2020-2034

    Figure 35: Latin America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

    Figure 36: Latin America Pharmaceutical Testing and Analytical Services Market Attractiveness Analysis, by Country/Sub-region, 2020-2034

    Figure 37: Latin America Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

    Figure 38: Latin America Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by Service Type, 2023 and 2034

    Figure 39: Latin America Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by End-user, 2023 and 2034

    Figure 40: Latin America Pharmaceutical Testing and Analytical Services Market Attractiveness Analysis, by Service Type, 2020-2034

    Figure 41: Latin America Pharmaceutical Testing and Analytical Services Market Attractiveness Analysis, by End-user, 2020-2034

    Figure 42: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

    Figure 43: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Attractiveness Analysis, by Country/Sub-region, 2020-2034

    Figure 44: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

    Figure 45: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by Service Type, 2023 and 2034

    Figure 46: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by End-user, 2023 and 2034

    Figure 47: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Attractiveness Analysis, by Service Type, 2020-2034

    Figure 48: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Attractiveness Analysis, by End-user, 2020-2034

Copyright © Transparency Market Research, Inc. All Rights reserved